ZA937315B - Anti-arrhythmic analgesically acting phthalazinone derivatives that brea through multi-drug resistance - Google Patents

Anti-arrhythmic analgesically acting phthalazinone derivatives that brea through multi-drug resistance

Info

Publication number
ZA937315B
ZA937315B ZA937315A ZA937315A ZA937315B ZA 937315 B ZA937315 B ZA 937315B ZA 937315 A ZA937315 A ZA 937315A ZA 937315 A ZA937315 A ZA 937315A ZA 937315 B ZA937315 B ZA 937315B
Authority
ZA
South Africa
Prior art keywords
analgesically
brea
arrhythmic
acting
drug resistance
Prior art date
Application number
ZA937315A
Other languages
English (en)
Inventor
Jueren Engel
Ilona Fleischhauer
Peter Metzenauer
Bernhard Kutscher
Stefan Szelenyi
Ulrich Werner
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of ZA937315B publication Critical patent/ZA937315B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
ZA937315A 1992-10-02 1993-10-01 Anti-arrhythmic analgesically acting phthalazinone derivatives that brea through multi-drug resistance ZA937315B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233113 1992-10-02

Publications (1)

Publication Number Publication Date
ZA937315B true ZA937315B (en) 1994-04-22

Family

ID=6469448

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937315A ZA937315B (en) 1992-10-02 1993-10-01 Anti-arrhythmic analgesically acting phthalazinone derivatives that brea through multi-drug resistance

Country Status (18)

Country Link
US (1) US5556856A (xx)
EP (1) EP0590551B1 (xx)
JP (1) JP3623975B2 (xx)
CN (1) CN1088435A (xx)
AT (1) ATE144708T1 (xx)
AU (1) AU666773B2 (xx)
CA (1) CA2107548A1 (xx)
CZ (1) CZ199593A3 (xx)
DE (1) DE59304351D1 (xx)
DK (1) DK0590551T3 (xx)
ES (1) ES2096168T3 (xx)
GR (1) GR3022070T3 (xx)
HU (1) HUT65353A (xx)
MX (1) MX9306120A (xx)
RU (1) RU2106143C1 (xx)
SK (1) SK104493A3 (xx)
UA (1) UA26953C2 (xx)
ZA (1) ZA937315B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162616A (en) * 1997-04-16 2000-12-19 Millennium Pharmaceuticals, Inc. Multidrug resistance-associated polypeptide
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US20030109448A1 (en) * 2001-11-07 2003-06-12 Crowley Kathleen S. Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
DE60335359D1 (de) 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7294701B2 (en) * 2003-04-02 2007-11-13 Technion Research & Development Foundation Ltd. Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
GB0428111D0 (en) * 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
US20090105225A1 (en) * 2006-04-20 2009-04-23 Glaxo Group Limited 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
US20090209520A1 (en) * 2006-06-15 2009-08-20 Kudos Pharmaceuticals Limited 2 -oxybenzamide derivatives as parp inhibitors
JP2009539963A (ja) * 2006-06-15 2009-11-19 クドス ファーマシューティカルズ リミテッド Ｐａｒｐ阻害剤
WO2007144637A1 (en) * 2006-06-15 2007-12-21 Kudos Pharmaceuticals Limited 2 -oxyheteroarylamide derivatives as parp inhibitors
UY30639A1 (es) 2006-10-17 2008-05-31 Kudos Pharm Ltd Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
DE602007005167D1 (de) * 2006-12-20 2010-04-15 Glaxo Group Ltd 4-benzyl-1(2h)-phthalazinone als h1-rezeptor-antagonisten
US20080280910A1 (en) * 2007-03-22 2008-11-13 Keith Allan Menear Phthalazinone derivatives
TW200900396A (en) * 2007-04-10 2009-01-01 Kudos Pharm Ltd Phthalazinone derivatives
US20090023727A1 (en) * 2007-07-05 2009-01-22 Muhammad Hashim Javaid Phthalazinone derivatives
WO2009034326A1 (en) 2007-09-14 2009-03-19 Astrazeneca Ab Phthalazinone derivatives
WO2009047336A1 (en) * 2007-10-11 2009-04-16 Glaxo Group Limited Phthalazine and pyrido [3,4-d] pyridaz ine compounds as h1 receptor antagonists
AU2008313467B2 (en) 2007-10-17 2013-08-29 Kudos Pharmaceuticals Limited 4- [3- (4-cyclopropanecarbonyl-piperazine-1-carbonyl) -4 -fluoro-benzyl] -2H-phthalazin-1-one
UY31603A1 (es) 2008-01-23 2009-08-31 Derivados de ftalazinona
CN102238945B (zh) * 2008-10-07 2014-10-29 阿斯利康(英国)有限公司 药物制剂514
AR079774A1 (es) * 2009-07-15 2012-02-22 Astrazeneca Ab Compuesto de ftalazinona como forma cristalina c , composicion farmaceutica y usos del mismo
CA2906008C (en) 2013-03-13 2019-07-09 Flatley Discovery Lab, Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222191B1 (de) * 1985-11-11 1991-01-30 ASTA Pharma AG 4-Benzyl-1-(2H)-phthalazinon-Derivate
JPH0667844B2 (ja) * 1987-03-06 1994-08-31 エーザイ株式会社 虚血性心疾患の治療・予防剤
US5110814A (en) * 1989-01-11 1992-05-05 Asta Pharma Ag Azelastine and its salts used to combat psoriasis

Also Published As

Publication number Publication date
MX9306120A (es) 1994-04-29
JPH06312928A (ja) 1994-11-08
AU666773B2 (en) 1996-02-22
EP0590551A3 (xx) 1994-08-31
HUT65353A (en) 1994-05-02
ES2096168T3 (es) 1997-03-01
CZ199593A3 (en) 1994-04-13
ATE144708T1 (de) 1996-11-15
SK104493A3 (en) 1994-08-10
US5556856A (en) 1996-09-17
HU9302784D0 (en) 1993-12-28
CN1088435A (zh) 1994-06-29
RU2106143C1 (ru) 1998-03-10
AU4876993A (en) 1994-04-14
EP0590551A2 (de) 1994-04-06
DE59304351D1 (de) 1996-12-05
GR3022070T3 (en) 1997-03-31
CA2107548A1 (en) 1994-04-03
DK0590551T3 (da) 1997-04-21
UA26953C2 (uk) 1999-12-29
JP3623975B2 (ja) 2005-02-23
EP0590551B1 (de) 1996-10-30

Similar Documents

Publication Publication Date Title
ZA937315B (en) Anti-arrhythmic analgesically acting phthalazinone derivatives that brea through multi-drug resistance
DE3778734D1 (de) Dibenzo(b,e)oxepin-derivate sowie antiallergische und entzuendunghemmende mittel.
FR2696176B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
FI894633A0 (fi) Foerfarande och anordning och presspassdon foer framstaellning av en fast, taet roerkoppling.
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
FI944204A0 (fi) Kondensoidut indolijohdannaiset, kuten 5HT4-reseptoriantagonistit
FI901148A0 (fi) Tetrahydrokinolinderivat som aer anvaendbara vid vaord av neurodegenerativa stoerningar.
NO894539D0 (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
ES2159749T3 (es) Derivados de bencilamino-2-metil-propanamidas 2-(4-sustituidas).
NO891191D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk virksomme catecholderivater.
DE68923131D1 (de) Bohrer, Schleifverfahren und Schleifvorrichtung.
DE3767178D1 (de) Heisshaertbare stoffgemische enthaltend substituierte bicyclo (2.2.1)hept-5-en-2,3-dicarbonsaeureimide und polymaleinimide.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
IT1230795B (it) Procedimento per preparare 1,1,1,2 tetrafluoroetano da 1,1 dicloro 1,2,2,2 tetrafluoroetano.
DE58907381D1 (de) Ungesättigte Derivate von 2,2,6,6-Tetramethylpiperidin.
DZ1718A1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
DE3584652D1 (de) 2,2,6,6-tetramethyl-4-piperidinyl-derivate und ihre verwendung als lichtstabilisatoren.
DK0935598T3 (da) 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet
NO891381D0 (no) Fremgangsmaate for fremstilling av nye fluorfosfonatnukleotidderivater.
NO893784D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktiveimidazolderivater.
NO894038L (no) Fremgangsmaate for fremstilling av nye 2-karbonyl-substituerte n,n'-di(trimetoksybenzoyl) piperaziner.
NO891025L (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktivesialosylglycerider.
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
NO894037D0 (no) Fremgangsmaate for fremstilling av nye 2-metoksykarbonyl-substituerte n,n'-di(trimetoksybenzoyl) piperaziner.
ITPS910013A1 (it) Testa multipla per foratrici, con attivazione esclusiva dei mandrini effettivamente utilizzati.